MyFinsight
Home
Blog
About
Cardio Diagnostics Holdings, Inc. (CDIO)
Cardio Diagnostics Holdings, Inc. (CDIO)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$1,490,324
Free Cash flow
-$1,342,364
Unit: Dollar
Positive Cash Flow Breakdown
Prepaid expenses and other curre...
Amortization
Depreciation
Others
Negative Cash Flow Breakdown
Net loss
Payments of finance agreement
Lease liability
Patent costs incurred
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,501,468
-1,788,158
-1,465,368
-1,714,536
Depreciation
44,283
44,240
44,220
40,402
Amortization
51,158
50,412
49,857
49,186
Stock-based compensation expense
24,352
24,733
24,083
24,762
Accounts receivable
-369
-3,852
-3,095
-1,706
Prepaid expenses and other current assets
-93,963
-138,627
-96,324
-162,888
Accounts payable and accrued expenses
7,112
25,528
-53,292
102,010
Lease liability
-62,133
-61,446
-60,768
-59,836
Net cash used in operating activities
-1,342,364
-1,562,212
-1,361,849
-1,393,418
Purchases of property and equipment
0
1,760
0
162,834
Patent costs incurred
46,789
61,936
78,359
94,985
Net cash used in investing activities
-46,789
-63,696
-78,359
-257,819
Proceeds from sale of common stock, net of issuance costs
0
3,693,470
263,068
116,646
Payments of finance agreement
101,171
101,171
67,448
76,691
Net cash provided by financing activities
-101,171
3,592,299
195,620
39,955
Net increase in cash
-1,490,324
1,966,391
-1,244,588
-1,611,282
Cash - beginning of period
7,077,021
5,110,630
6,355,218
7,827,487
Cash - end of period
5,586,697
7,077,021
5,110,630
6,355,218
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net increase in cash
-$1,490,324
(-1172.08%↓ Y/Y)
Prepaid expenses and
other current assets
-$93,963
(57.44%↑ Y/Y)
Amortization
$51,158
(-63.20%↓ Y/Y)
Depreciation
$44,283
(-41.30%↓ Y/Y)
Stock-based compensation
expense
$24,352
(-60.33%↓ Y/Y)
Accounts payable and
accrued expenses
$7,112
(118.27%↑ Y/Y)
Accounts receivable
-$369
(93.51%↑ Y/Y)
Net cash used in
operating activities
-$1,342,364
(54.83%↑ Y/Y)
Net cash provided by
financing activities
-$101,171
(-103.17%↓ Y/Y)
Net cash used in
investing activities
-$46,789
(43.72%↑ Y/Y)
Canceled cashflow
$221,237
Net loss
-$1,501,468
(54.75%↑ Y/Y)
Payments of finance
agreement
$101,171
(-56.03%↓ Y/Y)
Patent costs incurred
$46,789
(-20.22%↓ Y/Y)
Lease liability
-$62,133
(46.74%↑ Y/Y)
Buy us a coffee